CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Marshall Fordyce

Founder and Chief Executive Officer, Vera Therapeutics, Inc.

Search every verified Marshall Fordyce interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Marshall Fordyce, founder and chief executive officer of Vera Therapeutics, discussed his company’s recent progress and his approach to biotech leadership in two podcast appearances in October 2026. He described 2026 as a transformational year for Vera, citing the approval and commercial launch of its therapy for IgA nephropathy, and said the company is conducting a phase three trial with 428 patients. Fordyce framed the company’s mission as addressing autoimmune disease treatment without heavy reliance on steroids or broad immunosuppression, and emphasized the importance of scientific evidence, financial discipline, and patient-centered decisions in building and scaling a biotech. In these conversations, Fordyce detailed his trajectory from working as a physician to roles at Gilead and then founding Vera in 2016. He said his motivation grew from dissatisfaction with existing treatments for autoimmune diseases and other conditions, and noted that building a biotech requires navigating both scientific reality and market perception as a public company. He also highlighted the personal stakes for patients, including members of his own sales force living with IgA nephropathy, and described the company’s plans to expand its platform to other autoimmune patient populations.

Recent appearances

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →